Review



mpcr test filmarray 2.1 respiratory panel  (BioFire Defense)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    BioFire Defense mpcr test filmarray 2.1 respiratory panel
    Mpcr Test Filmarray 2.1 Respiratory Panel, supplied by BioFire Defense, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mpcr test filmarray 2.1 respiratory panel/product/BioFire Defense
    Average 90 stars, based on 1 article reviews
    mpcr test filmarray 2.1 respiratory panel - by Bioz Stars, 2026-03
    90/100 stars

    Images



    Similar Products

    mpcr test filmarray 2.1 respiratory panel  (BioFire Defense)
    90
    BioFire Defense mpcr test filmarray 2.1 respiratory panel
    Mpcr Test Filmarray 2.1 Respiratory Panel, supplied by BioFire Defense, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mpcr test filmarray 2.1 respiratory panel/product/BioFire Defense
    Average 90 stars, based on 1 article reviews
    mpcr test filmarray 2.1 respiratory panel - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    filmarray respiratory panel 2 & mpcr  (BioFire Defense)
    90
    BioFire Defense filmarray respiratory panel 2 & mpcr
    Filmarray Respiratory Panel 2 & Mpcr, supplied by BioFire Defense, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/filmarray respiratory panel 2 & mpcr/product/BioFire Defense
    Average 90 stars, based on 1 article reviews
    filmarray respiratory panel 2 & mpcr - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    mpcr testing using the biofire filmarray respiratory panel 2 (rp 2)  (BioFire Defense)
    90
    BioFire Defense mpcr testing using the biofire filmarray respiratory panel 2 (rp 2)
    Mpcr Testing Using The Biofire Filmarray Respiratory Panel 2 (Rp 2), supplied by BioFire Defense, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mpcr testing using the biofire filmarray respiratory panel 2 (rp 2)/product/BioFire Defense
    Average 90 stars, based on 1 article reviews
    mpcr testing using the biofire filmarray respiratory panel 2 (rp 2) - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    broad-panel respiratory mpcr filmarray pneumonia panel plus  (BioFire Defense)
    90
    BioFire Defense broad-panel respiratory mpcr filmarray pneumonia panel plus
    Trial design. In the intervention arm, before the end of day 1, clinicians have to consider all the early microbiological results <t>(mPCR</t> FA-PPP, urine antigen assays, blood cultures and Gram stain examination of <t>respiratory</t> tract sample) and procalcitonin before the end of day 1, and subsequently to apply an algorithm of early antibiotics discontinuation or de-escalation (red square). This algorithm is described in . In both arms, at day 3 and day after day until day 7, clinicians are encouraged to consider antibiotic discontinuation, based on procalcitonin values and kinetics. CAP, community-acquired pneumonia; FA-PPP, FilmArray Pneumonia Panel Plus; ICU, intensive care unit; mPCR, multiplex PCR.
    Broad Panel Respiratory Mpcr Filmarray Pneumonia Panel Plus, supplied by BioFire Defense, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/broad-panel respiratory mpcr filmarray pneumonia panel plus/product/BioFire Defense
    Average 90 stars, based on 1 article reviews
    broad-panel respiratory mpcr filmarray pneumonia panel plus - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    mpcr respiratory panel filmarray  (BioFire Defense)
    90
    BioFire Defense mpcr respiratory panel filmarray
    Background.
    Mpcr Respiratory Panel Filmarray, supplied by BioFire Defense, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mpcr respiratory panel filmarray/product/BioFire Defense
    Average 90 stars, based on 1 article reviews
    mpcr respiratory panel filmarray - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Trial design. In the intervention arm, before the end of day 1, clinicians have to consider all the early microbiological results (mPCR FA-PPP, urine antigen assays, blood cultures and Gram stain examination of respiratory tract sample) and procalcitonin before the end of day 1, and subsequently to apply an algorithm of early antibiotics discontinuation or de-escalation (red square). This algorithm is described in . In both arms, at day 3 and day after day until day 7, clinicians are encouraged to consider antibiotic discontinuation, based on procalcitonin values and kinetics. CAP, community-acquired pneumonia; FA-PPP, FilmArray Pneumonia Panel Plus; ICU, intensive care unit; mPCR, multiplex PCR.

    Journal: BMJ Open

    Article Title: Combined use of a broad-panel respiratory multiplex PCR and procalcitonin to reduce duration of antibiotics exposure in patients with severe community-acquired pneumonia (MULTI-CAP): a multicentre, parallel-group, open-label, individual randomised trial conducted in French intensive care units

    doi: 10.1136/bmjopen-2020-048187

    Figure Lengend Snippet: Trial design. In the intervention arm, before the end of day 1, clinicians have to consider all the early microbiological results (mPCR FA-PPP, urine antigen assays, blood cultures and Gram stain examination of respiratory tract sample) and procalcitonin before the end of day 1, and subsequently to apply an algorithm of early antibiotics discontinuation or de-escalation (red square). This algorithm is described in . In both arms, at day 3 and day after day until day 7, clinicians are encouraged to consider antibiotic discontinuation, based on procalcitonin values and kinetics. CAP, community-acquired pneumonia; FA-PPP, FilmArray Pneumonia Panel Plus; ICU, intensive care unit; mPCR, multiplex PCR.

    Article Snippet: In the experimental strategy arm, the microbiological diagnosis combines a broad-panel respiratory mPCR (FilmArray Pneumonia Panel Plus (FA-PPP), BioFire Biomérieux) with conventional microbiological investigations.

    Techniques: Staining, Multiplex Assay

    Algorithm of early antibiotics de-escalation or discontinuation. The algorithm is applied in the intervention arm only (see red square, ). mPCR, multiplex PCR; ICU, intensive care unit; PCT, procalcitonin.

    Journal: BMJ Open

    Article Title: Combined use of a broad-panel respiratory multiplex PCR and procalcitonin to reduce duration of antibiotics exposure in patients with severe community-acquired pneumonia (MULTI-CAP): a multicentre, parallel-group, open-label, individual randomised trial conducted in French intensive care units

    doi: 10.1136/bmjopen-2020-048187

    Figure Lengend Snippet: Algorithm of early antibiotics de-escalation or discontinuation. The algorithm is applied in the intervention arm only (see red square, ). mPCR, multiplex PCR; ICU, intensive care unit; PCT, procalcitonin.

    Article Snippet: In the experimental strategy arm, the microbiological diagnosis combines a broad-panel respiratory mPCR (FilmArray Pneumonia Panel Plus (FA-PPP), BioFire Biomérieux) with conventional microbiological investigations.

    Techniques: Multiplex Assay

    Primary and secondary outcomes

    Journal: BMJ Open

    Article Title: Combined use of a broad-panel respiratory multiplex PCR and procalcitonin to reduce duration of antibiotics exposure in patients with severe community-acquired pneumonia (MULTI-CAP): a multicentre, parallel-group, open-label, individual randomised trial conducted in French intensive care units

    doi: 10.1136/bmjopen-2020-048187

    Figure Lengend Snippet: Primary and secondary outcomes

    Article Snippet: In the experimental strategy arm, the microbiological diagnosis combines a broad-panel respiratory mPCR (FilmArray Pneumonia Panel Plus (FA-PPP), BioFire Biomérieux) with conventional microbiological investigations.

    Techniques: Bacteria, Biomarker Discovery

    Background.

    Journal: Journal of Infection and Chemotherapy

    Article Title: The impact analysis of a multiplex PCR respiratory panel for hospitalized pediatric respiratory infections in Japan ☆

    doi: 10.1016/j.jiac.2019.07.014

    Figure Lengend Snippet: Background.

    Article Snippet: We replaced rapid antigen tests with the mPCR respiratory panel (FilmArray®; Biofire, Utah, USA) as a microbiological diagnostic test for pediatric respiratory infections admitted since March 26, 2018.

    Techniques: Biomarker Discovery

    mPCR group chart.

    Journal: Journal of Infection and Chemotherapy

    Article Title: The impact analysis of a multiplex PCR respiratory panel for hospitalized pediatric respiratory infections in Japan ☆

    doi: 10.1016/j.jiac.2019.07.014

    Figure Lengend Snippet: mPCR group chart.

    Article Snippet: We replaced rapid antigen tests with the mPCR respiratory panel (FilmArray®; Biofire, Utah, USA) as a microbiological diagnostic test for pediatric respiratory infections admitted since March 26, 2018.

    Techniques:

    Outcomes.

    Journal: Journal of Infection and Chemotherapy

    Article Title: The impact analysis of a multiplex PCR respiratory panel for hospitalized pediatric respiratory infections in Japan ☆

    doi: 10.1016/j.jiac.2019.07.014

    Figure Lengend Snippet: Outcomes.

    Article Snippet: We replaced rapid antigen tests with the mPCR respiratory panel (FilmArray®; Biofire, Utah, USA) as a microbiological diagnostic test for pediatric respiratory infections admitted since March 26, 2018.

    Techniques:

    The number of pathogen detections by mPCR. Adeno; Adenovirus, Corona; Coronavirus HKU1, NL63, 229E or OC43, hMPV; human metapneumovirus, Rhino/Entero; Rhinovirus or Enterovirus, Flu; Influenza virus A, A H1, A H3, A H1-2009 or B, RS; Respiratory syncytial virus, Para; Parainfluenza virus 1, 2, 3 or 4, Mycoplasma; Mycoplasma Pneumoniae , Chlamydia; Chlamydia Pneumoniae , Pertussis; Bordetella pertussis .

    Journal: Journal of Infection and Chemotherapy

    Article Title: The impact analysis of a multiplex PCR respiratory panel for hospitalized pediatric respiratory infections in Japan ☆

    doi: 10.1016/j.jiac.2019.07.014

    Figure Lengend Snippet: The number of pathogen detections by mPCR. Adeno; Adenovirus, Corona; Coronavirus HKU1, NL63, 229E or OC43, hMPV; human metapneumovirus, Rhino/Entero; Rhinovirus or Enterovirus, Flu; Influenza virus A, A H1, A H3, A H1-2009 or B, RS; Respiratory syncytial virus, Para; Parainfluenza virus 1, 2, 3 or 4, Mycoplasma; Mycoplasma Pneumoniae , Chlamydia; Chlamydia Pneumoniae , Pertussis; Bordetella pertussis .

    Article Snippet: We replaced rapid antigen tests with the mPCR respiratory panel (FilmArray®; Biofire, Utah, USA) as a microbiological diagnostic test for pediatric respiratory infections admitted since March 26, 2018.

    Techniques: Virus